Schlumberger (SLB) is divesting parts of ChampionX to address UK regulatory concerns regarding their $7.8 billion merger, expecting the deal to close in Q2 or early Q3 2025 [4], [9]. While the company's stock has declined recently, underperforming the S&P 500 [2], it is considered undervalued compared to peers [2], [5]. Despite downward revisions to earnings estimates [2], SLB consistently beats expectations [3] and is projected to grow revenue in the current and next fiscal years [2], [5]. The company continues to invest in geothermal energy [1] and secured a significant drilling contract with Woodside Energy [7], showcasing its technological leadership. Upcoming Q1 2025 earnings will be released on April 25th [6].

Chevron (CVX) faces significant disruption to its Venezuelan oil exports due to revoked loading authorizations by PDVSA following tightened U.S. sanctions [1], [10]. This jeopardizes a significant portion of Chevron's production and impacts its supply chain [1]. Scotiabank downgraded Chevron to Sector Perform, citing potential reductions in its share buyback program from $17.5 billion to $10 billion annually [3], [4]. While Jim Cramer expressed a positive outlook on Chevron, highlighting its dividend yield and buybacks [2], the company's stock has underperformed the market recently [5]. Despite record 2024 production and shareholder returns [11], Chevron faces ongoing risks related to sanctions and geopolitical instability [8], as well as the potential impact of a lowered buyback rate on investor sentiment [3].

Henry Schein (HSIC) will release Q1 2025 earnings on May 5th [2]. Despite a recent 5.5% stock price increase attributed to a broader market rally [1], the company faces a declining consensus EPS estimate and a Zacks Rank of #4 (Sell) [1], [8], with concerns over declining organic revenue, slim projected revenue growth, and declining return on invested capital [5]. While the company received validation for its net-zero emissions targets by 2050 [3] and will showcase its products at the 2025 International Dental Show [6], its stock has declined since its last earnings report [8] and underperformed the S&P 500, with analysts revising estimates downwards [8]. Long-term opportunities exist with potential increased demand for dental consumables due to Utah's water fluoridation ban [4] and a focus on sustainability [3], but negative recent financial performance [7] presents challenges.

American Airlines (AAL) withdrew its full-year guidance due to economic headwinds and weaker domestic demand, despite a narrower-than-expected Q1 2025 loss [1]. Goldman Sachs downgraded AAL to Sell, citing a weak balance sheet and operating leverage, making it vulnerable to economic uncertainty [6], [10]. AAL settled its 2025 Convertible Senior Notes in cash, eliminating potential share dilution [11]. While billionaire Andreas Halvorsen's $236 million stake suggests upside potential [1], the company faces operational challenges, including a minor plane collision [2] and broader market volatility impacting stock performance [2], [8]. AAL will webcast its Q1 2025 earnings call on April 24th [4]. Despite some positive news like a tariff pause [5], [9] and a new Citi partnership [8], the overall outlook remains cautious.